{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:14:46Z","timestamp":1775474086271,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"am","delay-in-days":733,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.berh.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T11:15:34Z","timestamp":1542280534000},"page":"390-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comorbidities in spondyloarthritis including psoriatic arthritis"],"prefix":"10.1016","volume":"32","author":[{"given":"Anna","family":"Molt\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2018.09.002_bib2","article-title":"Peripheral spondyloarthritis: concept, diagnosis and treatment","author":"Molt\u00f3","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2009.06.021","article-title":"Comorbidities in patients with psoriasis","volume":"122","author":"Gottlieb","year":"2009","journal-title":"Ann J Med"},{"key":"10.1016\/j.berh.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/annrheumdis-2012-201610","article-title":"Psoriasis and phenotype of patients with early inflammatory back pain","volume":"72","author":"Richette","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3899\/jrheum.160762","article-title":"Takayasu arteritis and spondyloarthritis: coincidence or association? A study of 14 cases","volume":"44","author":"Riviere","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0735-1097(98)00393-3","article-title":"Aortic root disease and valve disease associated with ankylosing spondylitis","volume":"32","author":"Roldan","year":"1998","journal-title":"J Ann Coll Cardiol"},{"key":"10.1016\/j.berh.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/ard.51.5.652","article-title":"Echo cardiographic abnormalities in ankylosing spondylitis","volume":"51","author":"O'Neill","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib8","article-title":"Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS one"},{"key":"10.1016\/j.berh.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3899\/jrheum.160942","article-title":"Deaths associated with ankylosing spondylitis in France from 1969 to 2009","volume":"44","author":"Pratri","year":"2017","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib10","first-page":"1","article-title":"The role of comorbidity in the crisis of the current psychiatric classification system Phylosophy","volume":"16","author":"Aragona","year":"2009","journal-title":"Psychiatr Psychol"},{"key":"10.1016\/j.berh.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1370\/afm.524","article-title":"Threads and yarns: Weaving the tapestry of comorbidity","volume":"4","author":"Starfield","year":"2006","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.berh.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib13","article-title":"Comorbidities in Spondyloarthritis associate with poor function, work disability and quality of life: Results from the ASAS-COMOSPA study","author":"Nikiphorou","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","article-title":"Inflammatory diseases and bone fragility","volume":"28","author":"Briot","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-010-1319-x","article-title":"Osteoporosis in inflammatory joint diseases","volume":"22","author":"Roux","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2018.09.002_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib17","first-page":"2205","article-title":"Osteoporosis, body composition, and bone turnover in ankylosing spondylitis","volume":"26","author":"El Maghraoui","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bone.2008.12.028","article-title":"Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis","volume":"44","author":"Ghozlani","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.berh.2018.09.002_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","article-title":"High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review","volume":"31","author":"van der Weijden","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201845","article-title":"Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort","volume":"72","author":"Briot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.100851","article-title":"Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis","volume":"38","author":"Montala","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/ard.2008.100503","article-title":"Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study","volume":"68","author":"Vosse","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3899\/jrheum.100363","article-title":"Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases -- a case-control study with 53,108 patients with fracture","volume":"37","author":"Weiss","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/rheumatology\/kem135","article-title":"Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis","volume":"46","author":"Vosse","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2018.09.002_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000052","article-title":"Inflammation, bone loss and fracture risk in spondyloarthritis","volume":"1","author":"Briot","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2018.09.002_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.6324","article-title":"OP0054 Incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the desir cohort","volume":"76","author":"Sahuguet","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","article-title":"Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort","volume":"55","author":"Briot","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-015-0809-9","article-title":"The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma","volume":"17","author":"Geusens","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00198-014-2939-3","article-title":"Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study","volume":"26","author":"Prieto-Alhambra","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","article-title":"Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"44","author":"Haroon","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bone.2017.09.010","article-title":"Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17\/N-cadherin mediated disruption of PTHR1\/LRP-6 interaction","volume":"105","author":"Mansoori","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.berh.2018.09.002_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.40017","article-title":"Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.berh.2018.09.002_bib33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.38339","article-title":"Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden","volume":"66","author":"Hellgren","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.berh.2018.09.002_bib34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ard.2005.047514","article-title":"Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib35","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/annrheumdis-2016-209270","article-title":"Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers","volume":"76","author":"Hellgren","year":"2017","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2018.09.002_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.23185","article-title":"Prevalence of malignancy in psoriatic arthritis","volume":"58","author":"Rohekar","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.09.002_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","article-title":"Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males","volume":"138","author":"S\u00f6derlund","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2018.09.002_bib39","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2002.004721","article-title":"Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study","volume":"62","author":"Feltelius","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.1987.35","article-title":"Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis","volume":"55","author":"Darby","year":"1987","journal-title":"Br J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.berh.2018.09.002_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.berh.2018.09.002_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2018.09.002_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12885-017-3757-8","article-title":"Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials","volume":"17","author":"Veettil","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.berh.2018.09.002_bib44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn\u2019s disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2010.09.734","article-title":"The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Dommasch","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.berh.2018.09.002_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/03009742.2013.834961","article-title":"Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis","volume":"43","author":"van der Heijde","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib47","article-title":"Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs","author":"Atzeni","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2018.09.002_bib48","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/annrheumdis-2014-205745","article-title":"TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study","volume":"74","author":"Raaschou","year":"2015","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2018.09.002_bib49","article-title":"Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study","author":"Dreyer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib50","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1136\/ard.2008.098822","article-title":"Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials","volume":"69","author":"Fouque-Aubert","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2018.09.002_bib51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/rheumatology\/keu255","article-title":"Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort","volume":"54","author":"Wallis","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2018.09.002_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib53","first-page":"584573","article-title":"The prevalence of fibromyalgia in other chronic pain conditions","volume":"2012","author":"Yunus","year":"2012","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.berh.2018.09.002_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.09.002_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4081\/reumatismo.2012.286","article-title":"Fibromyalgia and arthritides","volume":"64","author":"Atzeni","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.berh.2018.09.002_bib56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2018.09.002_bib57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","article-title":"Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity","volume":"34","author":"Salaffi","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2018.09.002_bib58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1590\/S0482-50042010000600005","article-title":"Occurrence of fibromyalgia in patients with ankylosing spondylitis","volume":"50","author":"Azevedo","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","article-title":"Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis","volume":"18","author":"Bello","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2018.09.002_bib60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2018.09.002_bib61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","article-title":"Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST)","volume":"150","author":"Perrot","year":"2010","journal-title":"Pain"},{"issue":"Suppl. 105","key":"10.1016\/j.berh.2018.09.002_bib63","first-page":"50","article-title":"Evaluation of whether extremely high enthesitis or Bath Ankylosing Disease Activity Index (BASDAI) scores suggest fibromyalgia and compound the anti-TNF response in early non-radiographic axial spondyloarthritis","volume":"35","author":"Dougados","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2018.09.002_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","article-title":"Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers'effectiveness in axial spondyloarthritis: results of a prospective multicentre study","volume":"77","author":"Molt\u00f3","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.09.002_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2018.09.002_bib66","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"Duru","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.berh.2018.09.002_bib69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/annrheumdis-2016-209233","article-title":"Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative","volume":"75","author":"Baillet","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.09.002_bib70","article-title":"Systematic screening of comorbidities improves vaccination rates, skin cancer screening and vitamin D supplementation in patients with axial spondyloarthritis: Results of the COMEDSPA prospective controlled one year randomized trial","author":"Molt\u00f3","year":"2018","journal-title":"EULAR"},{"key":"10.1016\/j.berh.2018.09.002_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbspin.2017.05.021","article-title":"Development of a comorbidity self-questionnaire for patients with inflammatory joint disease","volume":"85","author":"Pouplin","year":"2018","journal-title":"Joint Bone Spine"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:41Z","timestamp":1761499121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694218300512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1521694218300512"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.09.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities in spondyloarthritis including psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}